Approval Geography: Novel Agent Landscape Across US And EU

Pink Sheet infographic shows how a large majority of novel drugs make it past the US FDA before receiving approval in the European Union. Lag times ranged from almost five years to less than two weeks.

US-EU-Time-sign-post
Drug applications can go several different ways in their transatlantic journeys. • Source: Shutterstock

More from Regional Comparisons

More from Pink Sheet